In recent years, some scholars have established a liver-specific AMPKα1/α2 double-knockout and diet-induced obesity and NAFLD mouse model through genetic engineering technology (Garcia et al., 2019; Zhao et al., 2020). This evidence concerns the gene PRKAA1 and metabolic dysfunction-associated steatotic liver disease.